Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Avida is gearing up - sees great growth potential in the Nordic corporate market.

With the goal of becoming one of the leading specialist lenders in the Nordic region in both consumer and business finance, Avida is undertaking strategic investments in its business finance footprint so as to take advantage of the great growth potential that exists in the Nordic corporate market.This investment comes as a result of the strategy review that the board and management team of the company conducted during the first half of this year. Varun Khanna, Chairman of the Board of Avida and representative of the company's main shareholder, KKR, says: “We believe that there is a

Shaikan Payment Update

3 September 2021 Gulf Keystone Petroleum Ltd. (LSE: GKP)("Gulf Keystone", "GKP" or "the Company")  Shaikan Payment Update Gulf Keystone confirms that a gross payment of $37.6 million ($29.5 million net to GKP) has been received from the Kurdistan Regional Government ("KRG"). The payment is comprised of gross $31.7 million ($24.8 million net) for Shaikan crude oil sales during June 2021 and gross $6.0 million ($4.7 million net) in relation to the arrears from the outstanding November 2019 to February 2020 invoices. Following receipt of the arrears payment calculated based on

CS MEDICA A/S issue of units prior to listing was oversubscribed

On August 31[st], 2021, the subscription period in CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) IPO of units (shares and consideration free warrants) prior to the planned listing on Spotlight Stock Market ended. The initial part of the IPO of units was subscribed to a total of approximately DKK 35.2 million, corresponding to a subscription ratio of approximately 158 percent. The Company will thus receive approximately DKK 22.3 million of which approximately DKK 3.9 million pertains to bridge loan, and approximately DKK 0.8 million is attributable to compensation (in the form of units) to

Hynion and Hyrex to cooperate on hydrogen stations for leisure boats

Hynion AS and Hyrex AS will cooperate to expand hydrogen filling stations for leisure boats. Hyrex has developed HyCruiser 28, a day cruiser with a hydrogen-electric powertrain.“As Hynion now builds a network of hydrogen filling stations in Norway and Sweden, we see exciting opportunities in ports as well. Although other forms of transport account for more emissions than recreational boats, this is also a significant segment, and the Norwegian authorities have stated clearly that emissions from recreational boats should be halved. It’s very hard to see how this could happen without the use

Multiple PSV contracts in West Africa

Solstad Offshore ASA is pleased to announce multiple new medium-term contracts in West Africa. Letter of Agreements have been signed with key clients for 7 PSVs, all with commencement Q4 2021 / Q1 2022. The total firm duration of the contracts is approximately 1,000 vessel days with options to extend the contracts further. Skudeneshavn, September 3[rd], 2021 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

Preem invests heavily in rapid charging

The fuel company Preem is investing heavily in rapid charging and has signed an agreement with Recharge to install hundreds of rapid chargers at Preem's stations throughout the country.Preem is now developing its stations together with the leading charging operator Recharge. Preem's stations will initially be equipped with four to eight charging points that will have an output of 150 kW up to 300 kW, which enables considerably faster charging. “This is part of Preem's renewable transition and our strategy to offer more environmentally efficient forms of energy at our stations. By

Trill Impact raises EUR 900 million for its inaugural Fund

Trill Impact has closed EUR 900 million in commitments for its inaugural impact mid-market buyout Fund (“the Fund”) from prominent institutional investors globally, making it one of the largest first-time-funds raised during the COVID-19 pandemic by an independent private investments firm.Trill Impact was founded in 2019 by Jan Ståhlberg and is today one of the largest dedicated impact investing houses in Europe with more than EUR 1 billion in assets under management across its private equity and microfinance investment advisory strategies. Despite the fundraising occurring in

Bio-Works adds distributor coverage in Croatia and Slovenia in deal with BIA d.o.o.

Bio-Works Technologies AB (Uppsala, Sweden) and BIA d.o.o. (Ljubljana, Slovenia) have signed a distribution agreement through which BIA will provide Bio-Works' next generation chromatography resins and prepacked columns to customers in Croatia and Slovenia.  Bio-Works' patented resins, WorkBeads™, are well-suited not only for the purification of biological compounds at laboratory scale but also for biopharmaceuticals at large scale, including peptides and recombinant proteins. Bio-Works has a broad portfolio of resin technology, including immobilized affinity chromatography (IMAC), size

Heimstaden Issues EUR 400m Senior Unsecured Bond

Heimstaden AB yesterday successfully issued a EUR 400 million fixed rate senior unsecured bond under its MTN programme with a maturity of 5.5 years. The bond carries an annual coupon of 4.375% and a yield of 4.500%. An application will be made for the bond to be listed on Nasdaq Stockholm. The final listing particulars, once published, will be made available on www.heimstaden.com. J.P. Morgan and Swedbank acted as Joint Bookrunners for the issue.  Contact:Arve Regland, CFO+47 47 90 77 00arve.regland@heimstaden.com Adam Lindh, Head of Treasury+46 708-83 96 74adam.

Holmström Fastigheter Holding’s subsidiary F Holmström Holding 6 AB completes the public offer to the sharesholders of Magnolia Bostad

F Holmström Holding 6 AB, reg.no. 559279-7376 (“FHH”), a company which together with inter alia Holmström Fastigheter Holding AB (publ), reg.no. 559286-6809 (“Holmström Holding”) is included in Holmströmgruppen, announced on 7 July 2021 a recommended cash offer to the shareholders of Magnolia Bostad AB, reg.no. 556797-7078 (“Magnolia Bostad” or “the Company”) to tender all of their shares in Magnolia Bostad to FHH (the “Offer”). FHH has today announced the outcome after the extended acceptance period and that the Offer is completed. Furthermore, FHH has announced an offer to acquire

Scandinavian ChemoTech is carrying out a directed new share issue and will receive approximately MSEK 18

Scandinavian ChemoTech AB (publ) (“ChemoTech” or “the Company”) hereby announces that the Company has carried out a directed new share issue which will provide the Company with approximately MSEK 18 before transaction costs. The capital injection enables an upshift of the Company's long-term strategy.The Board of ChemoTech has, with the support of authorisation from the Annual General Meeting on May 24, 2021, decided on a directed new issue of 874,211 Series B shares at a subscription price of SEK 20.59 per share. The subscription price corresponds to a discount of approximately 15 percent

BoMill’s long-term incentive program for employees fully subscribed

On May 6, 2021, the Annual General Meeting of BoMill AB resolved on an long-term incentive program through a directed issue of 200,000 warrants of series B 2021-2024 that entitles senior executives and other employees of BoMill the right to subscribe for new shares in the company. The last day for subscription of warrants was August 30, 2021, and the directed issue of warrants was fully subscribed.The purpose of the incentive program is to strengthen the employees of the company´s interest and incentives for the company’s financial growth. The rights to subscribe were offered to the CEO and

Lipum’s toxicology- and safety studies on the candidate drug SOL-116 progress according to plan

Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum’s candidate drug (SOL-116) have been completed according to plan and the final Clinical Trial Application (CTA)-enabling toxicology study has now started.The non-clinical program for toxicology- and safety studies of Lipum’s candidate drug (SOL-116) is carried out in collaboration with the contract research organisation (CRO) Charles River Laboratories. Previous dose finding studies, which included various dose levels, were conducted in two different species with a treatment period of four weeks.

Realheart enters partnership with software experts Codialist

Realheart's artificial heart consists of two parts: an internal heart unit and an external control unit that is the brain of the system. The control unit software is now being tested to develop the final version in preparation for human clinical trials. This is being done in collaboration with medical device software experts Codialist.Codialist is a software development firm for medical devices with special expertise in heart pump technologies having been spun off from Berlin Heart GmbH, a world-leading German manufacturer of assistive devices for patients with end-stage heart failure.

Record date for the allotment of warrants of series TO3 to shareholders in Wyld Networks AB

As Wyld Networks AB (”Wyld Networks” or the "Company") communicated on August 24, 2021 the board of directors decided to issue warrants of series TO3 (the “Warrants”) to the current shareholders of Wyld Networks who on the record date, September 8, 2021, holds shares in the Company.The record date to receive warrants of series TO3 has been set to September 8, 2021. Therefore, the last day of trading in the Company’s share including the right to receive warrants of series TO3 is September 6, 2021, and the first day of trading in the Company’s share excluding the right to receive warrants of

Sectra’s three-month interim report 2021/2022: Early deliveries have a positive effect on the period—not expected to affect the full year

Press release – Linköping, September 3, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has significant variations in financial outcomes between periods and its earnings have traditionally been low during the first quarter of the year. This year, some deliveries, primarily in the US, were carried out earlier than planned and operating profit subsequently increased to SEK 90.1 million, which is high for a first quarter. This strong start to the year is not expected to affect the company’s outcome for the fiscal year as a

Receipt of regulatory approval from the NFSA regarding the recommended voluntary cash offer for all outstanding shares in Bank Norwegian ASA

NOT FOR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA AND JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE PRIOR APPROVAL. FOR MORE INFORMATION ABOUT NORDAX'S VOLUNTARY OFFER, PLEASE SEE NORDAX'S FORMAL OFFER ANNOUNCEMENT, AVAILABLE AT: WWW.COLLABORATE-TO-SCALE.COM.Reference is made to the offer document dated 5 August 2021 (the "Offer Document") and the stock exchange announcement on the same day for the recommended voluntary offer by Nordax Bank AB (publ) ("Nordax" or the "Offeror") to acquire all outstanding shares (the "Shares") in Bank

XNK Therapeutics appoints Markus Thor as Chief Business Officer

Sept. 3, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Markus Thor as Chief Business Officer, effective September 6[th]. He will be member of the company’s management team. Mr. Thor is an experienced business development executive with 25 years’ experience from the life science industry. In previous roles he was responsible for structuring, negotiating and closing a range of global, strategic business agreements, including in- and out-licensing, acquisitions and R&D collaborations. Prior to joining XNK, Mr. Thor worked more than a decade at Biovitrum AB,

CapMan Real Estate acquires industrial property in Köping

CapMan Real Estate Press Release3 September 2021 at 09:00 a.m. EEST CapMan Real Estate acquires industrial property in Köping CapMan Nordic Real Estate Fund III has agreed to acquire a property in Köping by entering into a sale and leaseback agreement for four years. The property consists of approximately 60,000 sqm of land and 35,000 sqm of industrial and storage space. The location in Köping is favourable from a logistics point of view. This is the second industrial asset which CapMan Nordic Real Estate acquires in the Mälardalen area as it bought the Assa lock

Notice of Annual General Meeting of Flexion Mobile Plc

If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice from your stockbroker or other independent adviser authorised under the Financial Services and Markets Act 2000. Notice of Annual General Meeting FLEXION MOBILE PLC Notice is hereby given that the 2021 annual general meeting ("AGM") of Flexion Mobile Plc ("Company") will be held at Flexion Mobile Plc, Unit G5, Harbour Yard, Chelsea Harbour, London, SW10 0XD, UK on 29[th]  September 2021 at 2.00 pm.  You will be asked to consider and vote on the resolutions below. Of

Lambi introduces new easy-to-use Home Towel household sheets

Lambi, a brand of Metsä Tissue, launches the new, easy-to-use Home Towel household sheets to ease the life of those who value functionality, high quality and design. One Lambi Home Towel package has the same amount of paper as two and a half regular household kitchen rolls. The conveniently folded, individual sheets can be used with a single hand. One sheet at a time.Household sheets are a great helper in the everyday life and they bring the convenience of household paper to the next level. Thanks to the compact form of the product, it requires less storage space and most importantly, it is

Peab builds a parking garage and office space in Turku

Peab has been commissioned to build a parking garage and commercial space in Turku. The customer is Reale Rakennus Oy and Litu Oy and the contract is worth EUR 15 million.Peab has been commissioned to build a parking garage and commercial space in Turku. The customer is Reale Rakennus Oy and Litu Oy and the contract is worth EUR 15 million. The project entails building an underground two level parking garage, commercial space on the ground floor and offices on the second. The new complex will also be the foundation for four new future apartment buildings that will be built on top of it.

First Episealer® Talus surgery planned in Spain

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Spain has been scheduled. “We are continuing to execute on our international strategy, and I am pleased with having the first Episealer® Talus surgery in Spain scheduled. This also means that during 2021, we have had customers in 15 countries globally. Given that we are still early on our development curve, I believe that says something about our level om ambition”, says Pål Ryfors, CEO Episurf Medical.

Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria

03 September 2021 07:00 BST Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria Approval based on interim results from Phase III trial demonstrating complete terminal complement inhibition with reduced dosing frequency compared to Soliris Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children (with a body weight of 10 kg or above) and adolescents with paroxysmal nocturnal haemoglobinuria (PNH), an ultra-rare and severe blood disorder characterised by the destruction of red blood cells that

There are no items matching the current filter
There are no more items matching the current filter
Back to top